Jose Carmona

CIK: 0001693612

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADCT

ADC Therapeutics SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ADCT
ADC Therapeutics SA
Jun 30, 2026
Award(A)
Direct
203.7K shares-
ADCT
ADC Therapeutics SA
Feb 13, 2026
Award(A)
Direct
271.6K shares at avg. $3.99$1.1M
ADCT
ADC Therapeutics SA
Feb 13, 2026
Tax Payment(F)
Direct
25.9K shares at avg. $3.99$103K
ADCT
ADC Therapeutics SA
Dec 6, 2025
Tax Payment(F)
Direct
53.2K shares at avg. $3.29$175K
ADCT
ADC Therapeutics SA
Feb 13, 2025
Award(A)
Direct
240K shares at avg. $1.61$386K
ADCT
ADC Therapeutics SA
Dec 6, 2024
Tax Payment(F)
Direct
48.1K shares at avg. $3.13$151K

		Type	Shares	Price		Ownership
Jun 30, 2026	ADCT ADC Therapeutics SA	Award(A)	203,700	-	$0	Direct
Feb 13, 2026	ADCT ADC Therapeutics SA	Award(A)	271,600	$3.99	$1,083,684	Direct
Feb 13, 2026	ADCT ADC Therapeutics SA	Tax Payment(F)	25,880	$3.99	$103,261	Direct
Dec 6, 2025	ADCT ADC Therapeutics SA	Tax Payment(F)	53,236	$3.29	$175,146	Direct
Feb 13, 2025	ADCT ADC Therapeutics SA	Award(A)	240,000	$1.61	$386,400	Direct
Dec 6, 2024	ADCT ADC Therapeutics SA	Tax Payment(F)	48,108	$3.13	$150,578	Direct

1-6 of 6 transactions

About Carmona Jose

Carmona Jose (SEC CIK 0001693612) files insider reports with the SEC as Chief Financial Officer of ADC Therapeutics SA (ADCT).

Signal8 holds 5 ownership filings by Carmona Jose, all Form 4s, filed between Dec 9, 2024 and Jul 2, 2026. Those filings report 6 transactions, from Dec 6, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Carmona Jose's filings is in NEW PROVIDENCE, NJ.

Recent filings by Carmona Jose

Jun 30, 2026: Grant or award of ADCT shares (Form 4, code A).
Feb 13, 2026: Grant or award of ADCT shares (Form 4, code A).
Feb 13, 2026: Tax withholding of ADCT shares (Form 4, code F).
Dec 6, 2025: Tax withholding of ADCT shares (Form 4, code F).
Feb 13, 2025: Grant or award of ADCT shares (Form 4, code A).

Other insiders filing for ADC Therapeutics SA (ADCT)

Zaki Mohamed, Chief Medical Officer
GRAHAM PETER J, Chief Legal Officer
MALLIK AMEET, Chief Executive Officer
Azelby Robert, Director
Squarer Ron, Director
Sandor Victor, Director

How to read Form 4 transaction codes